Manhattan Competitors

Pink Sheets . USA . 
Stock . Manhattan Scients
MHTX Stock  USD 0.0008  0.0001  11.11%   
Manhattan Scients competes with Cannabix Technologies, Accelerate Diagnostics, Venus Concept, Bluejay Diagnostics, and Movano; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Manhattan Scients competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Manhattan Scients to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Manhattan Scients Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Manhattan Scients competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Manhattan Scients' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00111.61
Details
Intrinsic
Valuation
LowRealHigh
0.000.000811.61
Details
Naive
Forecast
LowNextHigh
0.0000150.000811.61
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00090.00090.0009
Details

Manhattan Scients Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Manhattan Scients and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Manhattan and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Manhattan Scients does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
BJDX
+ 0.8
VPTDF
NVNO
+ 0.79
BJDX
BLOZF
+ 0.77
VPTDF
MOVE
+ 0.74
VERO
MOVE
+ 0.72
BLOZF
BJDX
+ 0.71
BLOZF
  
High negative correlations   
MOVE
- 0.75
NMRD
NMRD
- 0.58
BLOZF
INVO
- 0.52
MOVE
NMRD
- 0.5
VPTDF
NVNO
- 0.49
AXDX
VERO
- 0.49
AXDX

Risk-Adjusted Indicators

There is a big difference between Manhattan Pink Sheet performing well and Manhattan Scients Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Manhattan Scients' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
VPTDF  3.47 (0.33) 0.00 (2.29) 0.00 
 0.00 
 9.09 
(9.09)
 39.74 
BLOZF  2.21 (0.24) 0.00  0.68  0.00 
 0.00 
 3.13 
(5.71)
 21.18 
AXDX  3.05  0.11 (0.01)(0.09) 3.77 
(3.42)
 8.02 
(7.11)
 18.35 
VERO  6.53 (0.80) 0.00 (0.19) 0.00 
 0.00 
 14.71 
(13.79)
 94.50 
NMRD  4.82  0.51  0.04 (0.20) 5.23 
(6.03)
 14.29 
(9.72)
 35.66 
BJDX  6.60 (1.24) 0.00 (7.86) 0.00 
 0.00 
 13.03 
(13.14)
 120.52 
MOVE  3.69 (0.80) 0.00 (0.31) 0.00 
 0.00 
 9.44 
(8.81)
 35.49 
INVO  4.97  0.75  0.06 (0.11) 4.69 
(8.22)
 6.67 
(6.85)
 105.62 
NVNO  2.73 (0.67) 0.00 (1.07) 0.00 
 0.00 
 4.22 
(4.76)
 33.20 
OPGN  3.84 (0.75) 0.00 (8.98) 0.00 
 0.00 
 7.05 
(12.02)
 39.12 
All Fundamental Data

Manhattan Scients Competitive Analysis

The better you understand Manhattan Scients competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Manhattan Scients' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Manhattan Scients' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MHTX VPTDF BLOZF AXDX VERO NMRD BJDX MOVE INVO NVNO
 11.11 
 0.0008 
Manhattan
 1.42 
 0.10 
VentriPoint
 3.45 
 0.28 
Cannabix
 1.76 
 1.67 
Accelerate
 3.33 
 0.29 
Venus
 1.06 
 0.93 
Nemaura
 1.74 
 3.50 
Bluejay
 5.65 
 3.18 
Movano
 3.45 
 0.84 
INVO
 2.08 
 3.30 
EnVVeno
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Out of control
Unstable
Extremely Dangerous
Very steady
Extremely Dangerous
Very risky
Out of control
Slightly risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Insignificant
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Very High
Below Average
High
Very High
Very High
Dangerous
Very High
Low
Dangerous
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Under Valued
Under Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Strong Buy
Hold
Not Available
Not Available
Buy
Not Available
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Hold
Cautious Hold
Cautious Hold
Buy
Not Rated
Strong Hold
Strong Hold
Not Rated
Strong Hold
Current Ratio
0.26
6.74
53.68
4.48
2.74
0.99
17.41
6.78
1.99
20.79
Net Asset
3.45 M
9.54 M
8.76 M
31.37 M
93.65 M
14.56 M
4.87 M
9.42 M
20.89 M
48.63 M
Profit Margin
N/A
N/A
N/A
N/A
-0.72
N/A
N/A
N/A
-1.23
N/A
EBITDA
(3.61 M)
(3.82 M)
(3.37 M)
(49.77 M)
(26.11 M)
(8.17 M)
(9.17 M)
(29.12 M)
(6.63 M)
(25.02 M)
Operating Margin
-13.38
-124.5
N/A
-2.88
-0.34
N/A
N/A
-31.99
-1.04
N/A
Current Valuation
4.33 M
28.27 M
34.49 M
80.64 M
35.97 M
22.58 M
(3.63 M)
8.8 M
15.19 M
10.64 M
Price To Book
15.64
8.27
6.9
N/A
0.21
122.56
0.26
1.95
5.97
1.22
Retained Earnings
(74.66 M)
(20.43 M)
N/A
(668.86 M)
(261.9 M)
(51.88 M)
(26.95 M)
(124.38 M)
(57.82 M)
(130.04 M)
Current Asset
5.36 M
1.07 M
N/A
91.68 M
N/A
9.55 M
N/A
138.64 M
N/A
N/A
Beta
1.74
0.28
2.51
0.6
0.64
0.046
0.73
0.19
1.44
1.22
Number Of Employees
1
17
11
134
304
36
10
30
25
31
Shares Outstanding
559.28 M
156.51 M
114.14 M
25.04 M
7.26 M
28.9 M
537.68 K
6.6 M
3.91 M
17.54 M
Cash Flow From Operations
(421 K)
(3.15 M)
(2.13 M)
(40.2 M)
(12.86 M)
(8.45 M)
(8.31 M)
(26.18 M)
(4.76 M)
(18.86 M)
Total Debt
143 K
125.38 K
N/A
39.22 M
79.7 M
20.03 M
370.11 K
252 K
8.68 M
1.4 M
Return On Equity
-2.51
-1.35
-0.39
N/A
-4.64
-7.24
-1.25
-1.81
-143.59
-0.59
Z Score
-12.9
N/A
N/A
N/A
N/A
-7.48
N/A
N/A
N/A
N/A
Return On Asset
-0.17
-0.64
-0.23
-0.76
-0.19
-0.49
-0.59
-0.89
-0.27
-0.37
Book Value Per Share
-0.002
0.034
0.066
-1.36
-2.53
-0.55
18.69
2.54
-1.59
2.7
Number Of Shares Shorted
N/A
N/A
N/A
510.51 K
1.45 M
52.57 K
21.06 K
128.34 K
1.95 K
507.89 K
Current Liabilities
1.29 M
3.05 M
N/A
4.45 M
N/A
658.01 K
N/A
40.62 M
N/A
N/A
Total Asset
3.45 M
9.54 M
8.76 M
31.37 M
93.65 M
14.56 M
4.87 M
9.42 M
20.89 M
48.63 M
Debt To Equity
0.093
0.022
N/A
2.76
7.84
N/A
0.036
0.025
0.6
0.04
Target Price
0.25
N/A
N/A
1.5
10.6
3.5
256.0
30.0
20.0
18.0
Short Ratio
N/A
N/A
N/A
7.77
0.69
0.3
0.09
3.76
0.04
3.63
Shares Owned By Institutions
0.3
N/A
0.04
17.45
27.03
7.7
0.95
13.84
3.0
29.76
Market Capitalization
4.5 M
32.09 M
34.73 M
41.82 M
2.1 M
2.43 M
1.88 M
27.72 M
3.25 M
57.87 M
Price To Earning
1.35
68.0
-12.89
-15.18
N/A
-707.14
N/A
39.53
N/A
N/A
Price To Earnings To Growth
N/A
N/A
N/A
-0.55
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
99.55
897.04
N/A
3.42
0.0301
804.62
54.99
24.76
0.56
N/A
Net Income
(3.64 M)
(3.88 M)
(3.37 M)
(61.62 M)
(37.05 M)
(14.14 M)
(9.95 M)
(29.28 M)
(8.03 M)
(23.52 M)
Earnings Per Share
-0.011
-0.018
-0.022
-2.59
-7.97
-0.39
-804.0
-5.8
0.69
-1.29
Shares Owned By Insiders
18.63
1.75
8.6
40.6
6.07
48.3
1.14
17.33
0.6
0.29
Revenue
50 K
N/A
N/A
12.06 M
76.35 M
77.04 K
N/A
N/A
3.02 M
N/A
Working Capital
4.08 M
(1.99 M)
N/A
12.43 M
44.41 M
(8.73 M)
1.45 M
2.62 M
(6.96 M)
45.55 M
Cash And Equivalents
386 K
7.29 M
7.88 M
36.77 M
6.78 M
14.75 M
15.34 M
21.3 M
1.96 M
37.48 M
Cash Per Share
N/A
0.05
0.07
0.45
0.1
0.61
0.76
0.65
0.16
3.96
Gross Profit
50 K
(6.27 K)
(6.6 M)
3.3 M
74.09 M
(1.48 M)
48.91 K
N/A
535.27 K
N/A
Day Typical Price
8.0E-4
0.0986
0.28
1.67
0.3
0.94
3.5
3.08
0.84
3.3
Accumulation Distribution
0.11
0.041
0.0345
0.0412
0.12
0.1
0.16
0.14
0.0805
0.0444
Market Facilitation Index
1.0E-4
0.0041
0.01
0.07
0.04
0.1
0.59
0.46
0.07
0.15
Daily Balance Of Power
(1.00)
0.3415
(1.00)
(0.43)
(0.25)
(0.10)
0.1017
0.3696
(0.43)
(0.47)
Period Momentum Indicator
(0.0001)
0.0014
(0.01)
(0.03)
(0.01)
(0.01)
0.06
0.17
(0.03)
(0.07)
Rate Of Daily Change
0.89
1.01
0.97
0.98
0.97
0.99
1.02
1.06
0.97
0.98
Day Median Price
9.0E-4
0.098
0.29
1.67
0.3
0.95
3.5
3.03
0.84
3.31
Price Action Indicator
(0.0001)
0.0028
(0.01)
(0.01)
(0.01)
(0.03)
0.035
0.24
(0.01)
(0.04)
Relative Strength Index
45.92
41.0
40.95
42.35
39.55
54.78
38.49
38.02
50.88
40.07
Coefficient Of Variation
(43,371)
(2,040)
(1,284)
6446.06
(2,320)
2006.49
(1,121)
(922.90)
2968.94
(762.46)
Mean Deviation
8.95
3.47
2.21
3.05
6.53
4.82
6.6
3.69
4.97
2.73
Jensen Alpha
0.002
(0.33)
(0.24)
0.1095
(0.80)
0.5084
(1.24)
(0.80)
0.7471
(0.67)
Total Risk Alpha
(1.61)
(1.14)
(0.75)
(0.48)
(2.08)
(0.57)
(2.99)
(1.32)
(1.18)
(1.21)
Sortino Ratio
N/A
N/A
N/A
(0.01)
N/A
0.04
N/A
N/A
0.0562
N/A
Downside Variance
N/A
N/A
N/A
16.68
N/A
35.41
N/A
N/A
28.13
N/A
Standard Deviation
12.08
6.31
3.53
4.06
11.95
6.97
13.56
5.47
12.1
4.57
Kurtosis
(0.22)
3.74
4.7
0.3735
20.81
2.18
28.92
4.98
43.34
19.5
Potential Upside
23.08
9.09
3.13
8.02
14.71
14.29
13.03
9.44
6.67
4.22
Treynor Ratio
0.0946
(2.29)
0.6849
(0.09)
(0.19)
(0.20)
(7.86)
(0.31)
(0.11)
(1.07)
Maximum Drawdown
50.0
39.74
21.18
18.35
94.5
35.66
120.52
35.49
105.62
33.2
Variance
146.0
39.75
12.49
16.49
142.82
48.54
183.92
29.97
146.3
20.87
Market Risk Adjusted Performance
0.1046
(2.28)
0.6949
(0.08)
(0.18)
(0.19)
(7.85)
(0.30)
(0.10)
(1.06)
Risk Adjusted Performance
0.0076
(0.03)
(0.05)
0.02
(0.02)
0.0469
(0.06)
(0.07)
0.0351
(0.09)
Skewness
0.4418
(0.08)
(0.27)
0.1455
3.59
1.11
4.14
(0.89)
6.01
(3.21)
Semi Deviation
N/A
N/A
N/A
3.77
N/A
5.23
N/A
N/A
4.69
N/A
Information Ratio
(0.01)
(0.07)
(0.11)
(0.01)
(0.05)
0.0341
(0.1)
(0.13)
0.0246
(0.16)
Value At Risk
(18.18)
(9.09)
(5.71)
(7.11)
(13.79)
(9.72)
(13.14)
(8.81)
(6.85)
(4.76)
Expected Short fall
N/A
N/A
N/A
(3.42)
N/A
(6.03)
N/A
N/A
(8.22)
N/A
Downside Deviation
N/A
N/A
N/A
4.08
N/A
5.95
N/A
N/A
5.3
N/A
Semi Variance
N/A
N/A
N/A
14.23
N/A
27.4
N/A
N/A
21.96
N/A

Manhattan Scients Competition Performance Charts

Five steps to successful analysis of Manhattan Scients Competition

Manhattan Scients' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Manhattan Scients in relation to its competition. Manhattan Scients' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Manhattan Scients in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Manhattan Scients' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Manhattan Scients, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Manhattan Scients position

In addition to having Manhattan Scients in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials Thematic Idea Now

Financials
Financials Theme
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Manhattan Pink Sheet Analysis

When running Manhattan Scients' price analysis, check to measure Manhattan Scients' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Manhattan Scients is operating at the current time. Most of Manhattan Scients' value examination focuses on studying past and present price action to predict the probability of Manhattan Scients' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Manhattan Scients' price. Additionally, you may evaluate how the addition of Manhattan Scients to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY